{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:24:27Z","timestamp":1791919467858,"version":"4.3.4"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Drug Metabolism and Pharmacokinetics"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/j.dmpk.2018.09.002","type":"journal-article","created":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T02:14:04Z","timestamp":1537236844000},"page":"241-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol"],"prefix":"10.1016","volume":"33","author":[{"given":"Lisa K.","family":"Stamp","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca L.","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Frampton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey N.","family":"Miner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony R.","family":"Merriman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Dalbeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.dmpk.2018.09.002_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.dmpk.2017.11.002","article-title":"Investigation of the transport of xanthine dehydrogenase inhibitors by the urate transporter ABCG2","volume":"33","author":"Nakamura","year":"2018","journal-title":"Drug Metabol Pharmacokinet"},{"issue":"5","key":"10.1016\/j.dmpk.2018.09.002_bib2","doi-asserted-by":"crossref","first-page":"5ra11","DOI":"10.1126\/scitranslmed.3000237","article-title":"Common defects of ABCG2, a high-capacity urate exporter, cause gout: a function-based genetic analysis in a Japanese population","volume":"1","author":"Matsuo","year":"2009","journal-title":"Sci Transl Med"},{"issue":"5","key":"10.1016\/j.dmpk.2018.09.002_bib3","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/cpt.89","article-title":"Genome-wide association study identifies ABCG2 (BCRP) as an allopurinol transporter and a determinant of drug response","volume":"97","author":"Wen","year":"2015","journal-title":"Clin Pharm Ther"},{"issue":"2","key":"10.1016\/j.dmpk.2018.09.002_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/tpj.2015.101","article-title":"ABCG2 loss-of-function polymorphism predicts poor response to allopurinol in patients with gout","volume":"17","author":"Roberts","year":"2017","journal-title":"Pharmacogenomics J"},{"key":"10.1016\/j.dmpk.2018.09.002_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/rheumatology\/kex467","article-title":"Association between ABCG2 rs2231142 and poor response to allopurinol: replication and meta-analysis","author":"Wallace","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/j.dmpk.2018.09.002_bib6","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat Commun"},{"issue":"3","key":"10.1016\/j.dmpk.2018.09.002_bib7","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.bbaexp.2005.10.003","article-title":"Identification of target genes of the transcription factor HNF1beta and HNF1alpha in a human embryonic kidney cell line","volume":"1731","author":"Senkel","year":"2005","journal-title":"Biochim Biophys Acta"},{"issue":"Suppl 10","key":"10.1016\/j.dmpk.2018.09.002_bib8","article-title":"A non-coding genetic variant maximally associated with serum urate levels is functionally linked to HNF4A-dependent PDZK1 expression","volume":"69","author":"Merriman","year":"2017","journal-title":"Arthritis Rheumatol"},{"issue":"4","key":"10.1016\/j.dmpk.2018.09.002_bib9","doi-asserted-by":"crossref","first-page":"F973","DOI":"10.1152\/ajprenal.00650.2016","article-title":"Regulation of PDZ domain-containing 1 (PDZK1) expression by hepatocyte nuclear factor-1\u03b1 (HNF1\u03b1) in human kidney","volume":"313","author":"Prestin","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"issue":"3","key":"10.1016\/j.dmpk.2018.09.002_bib10","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1038\/clpt.2011.113","article-title":"Relationship between serum urate and plasma oxypurinol in the management of gout: determination of minimum plasma oxypurinol concentration to achieve a target serum urate level","volume":"90","author":"Stamp","year":"2011","journal-title":"Clin Pharm Ther"},{"key":"10.1016\/j.dmpk.2018.09.002_bib11","article-title":"Plasma oxypurinol as a measure of adherence in clinical trials","author":"Stamp","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.dmpk.2018.09.002_bib12","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1136\/annrheumdis-2016-210872","article-title":"A randomised controlled trial of the efficacy and safety of allopurinol dose escalation to achieve target serum urate in people with gout","volume":"76","author":"Stamp","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.dmpk.2018.09.002_bib13","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1136\/annrheumdis-2017-211873","article-title":"Allopurinol dose escalation to achieve serum urate below 6mg\/dl: an open label extension study","volume":"76","author":"Stamp","year":"2017","journal-title":"Ann Rheum Dis"}],"container-title":["Drug Metabolism and Pharmacokinetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436718301095?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1347436718301095?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:53:41Z","timestamp":1761162821000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1347436718301095"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,12]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S1347436718301095"],"URL":"https:\/\/doi.org\/10.1016\/j.dmpk.2018.09.002","relation":{},"ISSN":["1347-4367"],"issn-type":[{"value":"1347-4367","type":"print"}],"subject":[],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ABCG2 rs2231142 (Q141K) and oxypurinol concentrations in people with gout receiving allopurinol","name":"articletitle","label":"Article Title"},{"value":"Drug Metabolism and Pharmacokinetics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dmpk.2018.09.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Ltd on behalf of The Japanese Society for the Study of Xenobiotics.","name":"copyright","label":"Copyright"}]}}